scispace - formally typeset
Open AccessJournal ArticleDOI

mTORC1 signaling and regulation of pancreatic β-cell mass

Reads0
Chats0
TLDR
It is demonstrated that deletion of Tsc1 in pancreatic β cells results in improved glucose tolerance, hyperinsulinemia and expansion of β-cell mass that persists with aging.
Abstract
The capacity of β cells to expand in response to insulin resistance is a critical factor in the development of type 2 diabetes. Proliferation of β cells is a major component for these adaptive responses in animal models. The extracellular signals responsible for β-cell expansion include growth factors, such as insulin, and nutrients, such as glucose and amino acids. AKT activation is one of the important components linking growth signals to the regulation of β-cell expansion. Downstream of AKT, tuberous sclerosis complex 1 and 2 (TSC1/2) and mechanistic target of rapamycin complex 1 (mTORC1) signaling have emerged as prime candidates in this process, because they integrate signals from growth factors and nutrients. Recent studies demonstrate the importance of mTORC1 signaling in β cells. This review will discuss recent advances in the understanding of how this pathway regulates β-cell mass and present data on the role of TSC1 in modulation of β-cell mass. Herein, we also demonstrate that deletion of Tsc1 ...

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal Article

Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. [Erratum: 2004 Sept. 23, v. 431, no. 7007, p. 485.]

TL;DR: In this article, S6K1-deficient mice are protected against obesity owing to enhanced β-oxidation, but on a high fat diet, levels of glucose and free fatty acids still rise in S6k1-dependent mice, resulting in insulin receptor desensitization.
Journal ArticleDOI

The emerging multiple roles of nuclear Akt

TL;DR: Evidence accumulated over the past 15 years has highlighted the presence of active Akt in the nucleus, where it acts as a fundamental component of key signaling pathways, and the most relevant findings about nuclear Akt are summarized.
Journal ArticleDOI

Insulin demand regulates β cell number via the unfolded protein response

TL;DR: A stem cell-independent model of tissue homeostasis is defined, in which differentiated secretory cells use the UPR sensor to adapt organ size to meet demand, suggesting that therapeutic UPR modulation has potential to expand β cell mass in people at risk for diabetes.
Journal ArticleDOI

mTORC1 Signaling: A Double-Edged Sword in Diabetic β Cells.

TL;DR: It is suggested that mTORC1 may act as a "double edge sword" in the regulation of β cell mass and function in response to metabolic stress such as nutrient overload and insulin resistance.
Journal ArticleDOI

Roles for PI3K/AKT/PTEN Pathway in Cell Signaling of Nonalcoholic Fatty Liver Disease

TL;DR: Molecular studies in the NAFLD support a key role for PTEN in hepatic insulin sensitivity and the development of steatosis, steatohepatitis, and fibrosis, and review recent studies on the features of the PTEN and the PI3K/AKT pathway.
References
More filters
Journal ArticleDOI

mTORC1-Mediated Cell Proliferation, But Not Cell Growth, Controlled by the 4E-BPs

TL;DR: Control of cell size and cell cycle progression appear to be independent in mammalian cells, whereas in lower eukaryotes, 4E-BPs influence both cell growth and proliferation.
Journal ArticleDOI

Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase.

TL;DR: It is demonstrated that homozygous disruption of the p70s 6k/p85s6k gene does not affect viability or fertility of mice, but that it has a significant effect on animal growth, especially during embryogenesis, and the finding of a new S6 kinase gene, which can partly compensate for p70S6k/ p85s 6K function, underscores the importance of S6K function in cell growth.
Journal ArticleDOI

Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1

TL;DR: Filtration of amino acids into humans leads to S6K1 activation, inhibition of insulin-induced class 1 PI3K activation, and insulin resistance, and S 6K1 may mediate deleterious effects, like insulin resistance and potentially type 2 diabetes in the face of nutrient excess.
Journal ArticleDOI

Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis

TL;DR: It is shown that contrary to the widely accepted model, this mutation does not affect the translational control of TOP mRNAs, and the size of rpS6(P-/-) MEFs, unlike wild-type MECs, is not further decreased upon rapamycin treatment, implying that the rPS6 is a critical downstream effector of mTOR in regulation of cell size.
Related Papers (5)